Nordea Investment Management Ab Neurocrine Biosciences Inc Transaction History

Nordea Investment Management Ab

  • $85.8 Billion
  • Q3 2024

A detailed history of Nordea Investment Management Ab transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 7,598 shares of NBIX stock, worth $954,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,598
Previous 27,942 72.81%
Holding current value
$954,688
Previous $3.85 Million 77.28%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$114.58 - $153.15 $2.33 Million - $3.12 Million
-20,344 Reduced 72.81%
7,598 $874,000
Q2 2024

Aug 08, 2024
BUY
$130.86 - $143.19 $164,752 - $180,276
1,259 Added 4.72%
27,942 $3.85 Million
Q1 2024

May 02, 2024
SELL
$130.4 - $143.74 $8,476 - $9,343
-65 Reduced 0.24%
26,683 $3.68 Million
Q4 2023

Jan 10, 2024
SELL
$106.07 - $132.76 $195,487 - $244,676
-1,843 Reduced 6.45%
26,748 $3.52 Million
Q3 2023

Nov 13, 2023
BUY
$94.02 - $117.1 $1.81 Million - $2.25 Million
19,238 Added 205.69%
28,591 $3.22 Million
Q2 2023

Jul 07, 2023
SELL
$89.53 - $104.87 $37,513 - $43,940
-419 Reduced 4.29%
9,353 $881,000
Q1 2023

Apr 19, 2023
SELL
$94.11 - $123.02 $298,705 - $390,465
-3,174 Reduced 24.52%
9,772 $989,000
Q4 2022

Feb 08, 2023
SELL
$106.72 - $127.06 $759,312 - $904,031
-7,115 Reduced 35.47%
12,946 $1.55 Million
Q3 2022

Oct 19, 2022
SELL
$92.03 - $107.81 $32.9 Million - $38.6 Million
-357,598 Reduced 94.69%
20,061 $2.1 Million
Q2 2022

Aug 09, 2022
SELL
$75.79 - $100.07 $10.8 Million - $14.3 Million
-142,851 Reduced 27.44%
377,659 $36.5 Million
Q1 2022

Apr 11, 2022
SELL
$72.45 - $94.81 $2.8 Million - $3.67 Million
-38,694 Reduced 6.92%
520,510 $48.6 Million
Q4 2021

Jan 20, 2022
BUY
$79.65 - $106.22 $7.68 Million - $10.2 Million
96,375 Added 20.82%
559,204 $47.6 Million
Q3 2021

Nov 01, 2021
SELL
$86.18 - $99.03 $39.9 Million - $45.8 Million
-462,829 Reduced 50.0%
462,829 $44.1 Million
Q3 2021

Nov 01, 2021
BUY
$86.18 - $99.03 $46.8 Million - $53.8 Million
542,972 Added 141.88%
925,658 $88.8 Million
Q2 2021

Jul 16, 2021
BUY
$89.43 - $102.27 $17.1 Million - $19.5 Million
191,140 Added 99.79%
382,686 $37.2 Million
Q1 2021

May 17, 2021
BUY
$87.57 - $119.4 $2.92 Million - $3.98 Million
33,344 Added 21.08%
191,546 $18.6 Million
Q4 2020

Feb 12, 2021
BUY
$86.91 - $108.33 $4.24 Million - $5.28 Million
48,738 Added 44.52%
158,202 $15.2 Million
Q3 2020

Nov 09, 2020
SELL
$96.16 - $135.15 $8.35 Million - $11.7 Million
-86,846 Reduced 44.24%
109,464 $10.8 Million
Q2 2020

Aug 13, 2020
BUY
$85.09 - $130.36 $9.42 Million - $14.4 Million
110,724 Added 129.37%
196,310 $23.9 Million
Q1 2020

May 15, 2020
BUY
$75.11 - $113.76 $709,939 - $1.08 Million
9,452 Added 12.41%
85,586 $7.76 Million
Q4 2019

Feb 11, 2020
SELL
$86.8 - $118.57 $5.32 Million - $7.27 Million
-61,347 Reduced 44.62%
76,134 $8.16 Million
Q3 2019

Nov 13, 2019
BUY
$83.82 - $101.5 $7.02 Million - $8.5 Million
83,777 Added 156.0%
137,481 $12.3 Million
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $1.06 Million - $1.34 Million
14,708 Added 37.72%
53,704 $4.54 Million
Q1 2019

May 20, 2019
BUY
$69.31 - $91.53 $32,229 - $42,561
465 Added 1.21%
38,996 $3.44 Million
Q3 2018

Nov 14, 2018
BUY
$98.88 - $125.85 $587,248 - $747,423
5,939 Added 18.22%
38,531 $4.74 Million
Q2 2018

Aug 13, 2018
SELL
$75.3 - $105.99 $319,497 - $449,715
-4,243 Reduced 11.52%
32,592 $3.2 Million
Q1 2018

May 14, 2018
BUY
$75.88 - $92.43 $249,189 - $303,540
3,284 Added 9.79%
36,835 $3.06 Million
Q4 2017

Feb 12, 2018
SELL
$58.53 - $77.59 $356,798 - $472,988
-6,096 Reduced 15.38%
33,551 $2.6 Million
Q3 2017

Nov 09, 2017
BUY
$47.97 - $61.28 $1.9 Million - $2.43 Million
39,647
39,647 $2.43 Million

Others Institutions Holding NBIX

# of Institutions
625
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email